Thursday, November 12, 2009

AMA Reverses Position on Pot

The American Medical Association reversed their previous ruling on marijuana earlier this week. They are now pushing for marijuana to be rescheduled so that further clinical trials can be performed regarding the usefulness of marijuana cannabinoids as medicine. Currently marijuana is a schedule 1 drug. It resides in the same classification as heroin, LSD, and MDMA.

According to the Controlled Substances Act, schedule 1 drugs have:
  • High potential for abuse
  • Currently no medical use in the United States
  • A lack of accepted safety for use of the drug or other substance under medical supervision.
Read more about it on the NORML's Blogpost.
Our AMA urges that marijuana’s status as a federal Schedule I controlled substance be reviewed with the goal of facilitating the conduct of clinical research and development of cannabinoid-based medicines, and alternate delivery methods. This should not be viewed as an endorsement of state-based medical cannabis programs, the legalization of marijuana, or that scientific evidence on the therapeutic use of cannabis meets the current standards for a prescription drug product.

No comments: